Sudden cardiac death in patients with kidney failure on renal replacement therapy: An unsolved problem

IF 5.7 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Heart rhythm Pub Date : 2025-03-21 DOI:10.1016/j.hrthm.2025.03.1970
Simonetta Genovesi MD , Giulia Lieti MD , A. John Camm MD
{"title":"Sudden cardiac death in patients with kidney failure on renal replacement therapy: An unsolved problem","authors":"Simonetta Genovesi MD ,&nbsp;Giulia Lieti MD ,&nbsp;A. John Camm MD","doi":"10.1016/j.hrthm.2025.03.1970","DOIUrl":null,"url":null,"abstract":"<div><div>Sudden cardiac death is an important cause of mortality in patients with kidney failure undergoing renal replacement therapy, either hemodialysis or peritoneal dialysis. The risk factors associated with sudden cardiac death in these patients only partly overlap with those in the general population. Kidney failure per se and hemodialysis therapy expose these patients to an increased risk of sudden cardiac death compared with individuals with preserved renal function. Studies of the implantable cardioverter defibrillator for primary prevention of sudden cardiac death in patients with kidney failure have failed to demonstrate its usefulness. Moreover, the incidence of complications associated with cardiac electronic device implantation in this population is extremely high.</div><div>This review aims to provide an update on the available studies on the pathophysiology and prevention of sudden cardiac death in patients with kidney failure undergoing dialysis and to propose the adoption of clinical practices to reduce its incidence.</div></div>","PeriodicalId":12886,"journal":{"name":"Heart rhythm","volume":"22 8","pages":"Pages e380-e387"},"PeriodicalIF":5.7000,"publicationDate":"2025-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Heart rhythm","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1547527125022325","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Sudden cardiac death is an important cause of mortality in patients with kidney failure undergoing renal replacement therapy, either hemodialysis or peritoneal dialysis. The risk factors associated with sudden cardiac death in these patients only partly overlap with those in the general population. Kidney failure per se and hemodialysis therapy expose these patients to an increased risk of sudden cardiac death compared with individuals with preserved renal function. Studies of the implantable cardioverter defibrillator for primary prevention of sudden cardiac death in patients with kidney failure have failed to demonstrate its usefulness. Moreover, the incidence of complications associated with cardiac electronic device implantation in this population is extremely high.
This review aims to provide an update on the available studies on the pathophysiology and prevention of sudden cardiac death in patients with kidney failure undergoing dialysis and to propose the adoption of clinical practices to reduce its incidence.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
肾替代治疗肾衰竭患者的心源性猝死:一个尚未解决的问题。
心源性猝死是肾衰竭患者接受肾替代治疗(血液透析或腹膜透析)的重要死亡原因。与这些患者的心源性猝死相关的危险因素与一般人群的危险因素只有部分重叠。与保留肾功能的患者相比,肾衰竭本身和血液透析治疗使这些患者心脏性猝死的风险增加。植入式心律转复除颤器对肾衰竭患者心源性猝死一级预防的研究未能证明其有效性。此外,在这一人群中,与心脏电子装置植入相关的并发症的发生率非常高。本综述旨在提供有关肾衰透析患者心源性猝死的病理生理学和预防的最新研究,并提出采用临床实践来降低其发生率的建议。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Heart rhythm
Heart rhythm 医学-心血管系统
CiteScore
10.50
自引率
5.50%
发文量
1465
审稿时长
24 days
期刊介绍: HeartRhythm, the official Journal of the Heart Rhythm Society and the Cardiac Electrophysiology Society, is a unique journal for fundamental discovery and clinical applicability. HeartRhythm integrates the entire cardiac electrophysiology (EP) community from basic and clinical academic researchers, private practitioners, engineers, allied professionals, industry, and trainees, all of whom are vital and interdependent members of our EP community. The Heart Rhythm Society is the international leader in science, education, and advocacy for cardiac arrhythmia professionals and patients, and the primary information resource on heart rhythm disorders. Its mission is to improve the care of patients by promoting research, education, and optimal health care policies and standards.
期刊最新文献
Lead failure and venous occlusion as potential drivers of extraction difficulty. Corrigendum to "Development and validation of a new disease-specific quality-of-life measure for atrial fibrillation derived from patient perspectives: The Atrial Fibrillation Patient-Reported Outcome Measures (AF-PROMs) Questionnaire," Heart Rhythm, Volume 22, Issue 8, P1922-1934, August 2025. Activation signature valleys are predictive of macroreentrant atrial tachycardia bottlenecks where uniform low voltage and uniform slow conduction reside. Antiarrhythmic Drugs Versus Catheter Ablation for Treatment of Atrial Fibrillation in An Elderly Population: A Retrospective Analysis of Medicare Advantage Enrollees in the United States. Class Ic antiarrhythmic drugs and structural heart disease - time for a randomized controlled study?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1